Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
505.00    4.50 (0.90%)
Bid:
505.00
Ask:
505.50
Spread: 0.50 (0.099%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

3 Oct 2025 10:00

RNS Number : 8934B
Tate & Lyle PLC
03 October 2025
Β 

Tate & Lyle PLC

Β 

Notification of transactions by Persons Discharging Managerial Responsibilities

Β 

Tate & Lyle PLC (the 'Company') has been informed that on 2 October 2025 the following transactions occurred by a Person Discharging Managerial Responsibilities ('PDMR') in respect of their purchase of American Depositary Receipts ('ADRs'), where each ADR represents an interest in four (4) ordinary shares of 29 1/6 pence each in the capital of the Company ('Shares').

Β 

PDMR

Number of ADR's acquired

Price per ADR

Glenn Fish

1,000

US$20.50

Β 

Following these purchases, Mr Fish is interested in a total of 5,049.828 ADRs, representing 20,199.3 Shares.

Β 

The notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provide further detail.

Β 

Matthew Joy

Company Secretary

3 October 2025

Β 

Β 

Notification and public disclosure of transaction by person discharging managerial responsibilities

Β 

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Glenn Fish

2.

Reason for the notification

a)

Position / status

Non-executive Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Β 

Identification code

American Depositary Receipts ('ADRs') each of which represents four (4) Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

Β 

Β 

US8765706077

b)

Nature of the transaction

Acquisition of ADR's

c)

Price(s) and volume(s)

Price per ADR

Volume(s)

US$20.50

1,000

d)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

1,000 ADRs

Β 

$20,500

e)

Date of the transaction

2 October 2025

f)

Place of the transaction

OTCQX exchange

OTCQX

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUURNRVSURRAA
Date   Source Headline
21st May 202612:15 pmRNSForm 8.3 - Tate & Lyle plc
21st May 202612:06 pmBUSForm 8.3 - Tate & Lyle
21st May 202611:53 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
21st May 202611:22 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
21st May 202611:13 amRNS20260520_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
21st May 202611:11 amRNS20260520_TATE & LYLE_8.5 EPT RI_UK_MLI
21st May 202611:09 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
21st May 202611:01 amRNSForm 8.3 TATE & LYLE PLC
21st May 202610:28 amRNSForm 8.3 - Tate & Lyle Plc
21st May 20268:29 amRNSForm 8.5 (EPT/RI)
21st May 20267:00 amRNSFinal Results
20th May 20264:28 pmRNSForm 8.5 - Tate & Lyle Plc
20th May 20264:26 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
20th May 20263:27 pmRNSForm 8.3 Tate & Lyle plc
20th May 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20262:49 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20262:03 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
20th May 20261:52 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20261:28 pmRNSForm 8.3 - Tate & Lyle plc
20th May 20261:22 pmRNSForm 8.3 TATE & LYLE PLC
20th May 202612:26 pmRNSForm 8.3 Tate & Lyle Plc
20th May 202612:05 pmRNSForm 8.3 - Tate & Lyle plc
20th May 202611:59 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle PLC
20th May 202611:58 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
20th May 202611:47 amRNSForm 8.3- TATE & LYLZ
20th May 202611:35 amRNS20260519_TATE & LYLE_8.5 EPT RI_UK_MLI
20th May 202611:15 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle Plc
20th May 202611:02 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
20th May 20269:21 amRNSForm 8.5 (EPT/RI)
20th May 20269:18 amRNSForm 8.3 - Tate and Lyle PLC
20th May 20267:33 amRNSForm 8.5 (EPT/RI) - Amend - Tate & Lyle PLC
19th May 20265:59 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
19th May 20265:51 pmRNSForm 8.3 - Tate & Lyle PLC
19th May 20263:39 pmRNSForm 8.3 TATE & LYLE PLC
19th May 20263:25 pmRNSForm 8.3 - Tate & Lyle PLC
19th May 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
19th May 20262:08 pmRNSForm 8.3 - Tate & Lyle plc
19th May 20262:00 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
19th May 202611:53 amRNSForm 8.5 (EPT/NON-RI) - Tate & Lyle PLC
19th May 202611:52 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
19th May 202611:15 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
19th May 202611:08 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
19th May 202611:06 amRNSForm 8.3 Tate & Lyle
19th May 202611:05 amRNSForm 8.3 - Tate & Lyle plc
19th May 202610:53 amBUSForm 8.3 - Tate & Lyle plc
19th May 202610:45 amRNSForm 8.3 - Tate & Lyle PLC
19th May 202610:19 amRNS20260518_TATE & LYLE_8.5 EPT RI_UK_MLI
19th May 20269:32 amRNSForm 8.5 (EPT/RI)
18th May 20265:50 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
18th May 20264:48 pmRNS20260514_TATE & LYLE_8.5 EPT RI_UK_MLI_replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.